[Long term development of adrenal gland insufficiency, designated regressive, in newborn infants].
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000309:Adrenal Insufficiency / Q000150:complications* / Q000188:drug therapy; D000450:Aldosterone / Q000652:urine; D001827:Body Height; D001835:Body Weight; D002648:Child; D002675:Child, Preschool; D003681:Dehydration / Q000209:etiology*; D005260:Female; D005470:Fluorometry; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D006947:Hyperkalemia / Q000209:etiology; D007223:Infant; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases; D008297:Male; D008543:Melanins; D010859:Pigmentation Disorders / Q000209:etiology*; D012640:Seizures / Q000209:etiology; D012965:Sodium Chloride / Q000652:urine; D013997:Time Factors
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D000305:Adrenal Cortex Hormones; D008543:Melanins; D012965:Sodium Chloride; D000450:Aldosterone; D006854:Hydrocortisone
Evolution lointaine d'une insuffisance surrénale, dite régressive, du nouveau-né.